🇺🇸 ANILERIDINE PHOSPHATE in United States

ANILERIDINE PHOSPHATE (ANILERIDINE PHOSPHATE) regulatory status in United States.

Marketing authorisations

FDA

  • Status: approved

FDA

  • Application: NDA010520
  • Marketing authorisation holder: MERCK
  • Local brand name: LERITINE
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

ANILERIDINE PHOSPHATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is ANILERIDINE PHOSPHATE approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for ANILERIDINE PHOSPHATE in United States?

Marketing authorisation holder not available in our data.